Merit Medical Systems, Inc. (MMSI) Shares Sold by Emerald Advisers Inc. PA

Emerald Advisers Inc. PA trimmed its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 21.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 213,891 shares of the medical instruments supplier’s stock after selling 58,680 shares during the period. Emerald Advisers Inc. PA owned 0.43% of Merit Medical Systems worth $9,240,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of MMSI. Wells Fargo & Company MN increased its position in Merit Medical Systems by 7.7% during the second quarter. Wells Fargo & Company MN now owns 112,183 shares of the medical instruments supplier’s stock worth $4,279,000 after purchasing an additional 8,065 shares during the last quarter. Alliancebernstein L.P. increased its position in shares of Merit Medical Systems by 15.2% during the second quarter. Alliancebernstein L.P. now owns 66,664 shares of the medical instruments supplier’s stock valued at $2,543,000 after acquiring an additional 8,800 shares during the last quarter. Nationwide Fund Advisors increased its position in shares of Merit Medical Systems by 4.5% during the second quarter. Nationwide Fund Advisors now owns 36,336 shares of the medical instruments supplier’s stock valued at $1,386,000 after acquiring an additional 1,555 shares during the last quarter. Amalgamated Bank acquired a new stake in shares of Merit Medical Systems during the second quarter valued at about $249,000. Finally, New York State Common Retirement Fund increased its position in shares of Merit Medical Systems by 17.1% during the second quarter. New York State Common Retirement Fund now owns 52,100 shares of the medical instruments supplier’s stock valued at $1,988,000 after acquiring an additional 7,599 shares during the last quarter. 87.44% of the stock is currently owned by institutional investors and hedge funds.

In other Merit Medical Systems news, Director Kent W. Stanger sold 2,918 shares of the company’s stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $44.55, for a total value of $129,996.90. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Franklin J. Miller sold 10,000 shares of the company’s stock in a transaction dated Friday, December 29th. The shares were sold at an average price of $43.93, for a total transaction of $439,300.00. The disclosure for this sale can be found here. Insiders sold a total of 32,000 shares of company stock worth $1,416,379 over the last quarter. Insiders own 5.00% of the company’s stock.

Merit Medical Systems, Inc. (MMSI) opened at $43.35 on Thursday. Merit Medical Systems, Inc. has a 12 month low of $27.25 and a 12 month high of $48.10. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.43 and a current ratio of 2.78. The firm has a market cap of $2,146.00, a price-to-earnings ratio of 33.66, a PEG ratio of 2.51 and a beta of 1.29.

Several research analysts have recently commented on the stock. Zacks Investment Research lowered shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Thursday, January 25th. BidaskClub lowered shares of Merit Medical Systems from a “hold” rating to a “sell” rating in a research note on Friday, January 26th. ValuEngine downgraded shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Wells Fargo & Co reiterated an “outperform” rating and issued a $51.00 price target (up previously from $46.00) on shares of Merit Medical Systems in a research note on Thursday, November 30th. Finally, SunTrust Banks set a $47.00 price objective on shares of Merit Medical Systems and gave the stock a “buy” rating in a research report on Thursday, November 16th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and ten have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $43.77.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Week Herald and is the sole property of of Week Herald. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://weekherald.com/2018/02/15/emerald-advisers-inc-pa-decreases-position-in-merit-medical-systems-inc-mmsi.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply